Compare BCO & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BCO | ICUI |
|---|---|---|
| Founded | 1859 | 1984 |
| Country | United States | United States |
| Employees | 125 | N/A |
| Industry | Oil Refining/Marketing | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.9B |
| IPO Year | 2009 | 1995 |
| Metric | BCO | ICUI |
|---|---|---|
| Price | $100.20 | $124.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | $154.00 | ★ $182.25 |
| AVG Volume (30 Days) | ★ 637.8K | 230.3K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.00% | N/A |
| EPS Growth | 29.20 | ★ 100.62 |
| EPS | ★ 4.69 | 0.03 |
| Revenue | ★ $3,562,300,000.00 | $2,231,262,000.00 |
| Revenue This Year | $7.22 | N/A |
| Revenue Next Year | $5.92 | $4.46 |
| P/E Ratio | ★ $21.67 | $4,255.33 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $80.10 | $107.02 |
| 52 Week High | $136.37 | $160.29 |
| Indicator | BCO | ICUI |
|---|---|---|
| Relative Strength Index (RSI) | 31.45 | 36.14 |
| Support Level | $96.49 | $122.17 |
| Resistance Level | $116.74 | $125.00 |
| Average True Range (ATR) | 3.43 | 4.94 |
| MACD | -0.34 | 0.20 |
| Stochastic Oscillator | 20.83 | 11.49 |
The Brink's Co is a provider of secure logistics and security solutions for cash and other valuables. Its segments include: North America segment includes operations in the U.S. and Canada, including the Brink's Global Services (BGS) line of business; Latin America segment consists operations in Latin American countries where it has an ownership interest, including the BGS line of business; Europe segment includes total operations in European countries that provide services outside of the BGS line of business; and Rest of World segment consists operations in the Middle East, Africa and Asia. It also includes total operations in European countries that provide BGS services and BGS activity in Latin American countries. It derives maximum revenue from the North America segment.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.